MedPath

Vancomycin Hydrochloride

Vancomycin Hydrochloride for Injection, USP

Approved
Approval ID

91c050cf-3b2d-48bc-7297-e8dc68225e5a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 22, 2022

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

VANCOMYCIN HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-1319
Application NumberANDA063076
Product Classification
M
Marketing Category
C73584
G
Generic Name
VANCOMYCIN HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2022
FDA Product Classification

INGREDIENTS (3)

VANCOMYCIN HYDROCHLORIDEActive
Quantity: 500 mg in 5 mL
Code: 71WO621TJD
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

VANCOMYCIN HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-6509
Application NumberANDA063076
Product Classification
M
Marketing Category
C73584
G
Generic Name
VANCOMYCIN HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2022
FDA Product Classification

INGREDIENTS (3)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
VANCOMYCIN HYDROCHLORIDEActive
Quantity: 500 mg in 10 mL
Code: 71WO621TJD
Classification: ACTIM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.